2022–2023 mpox outbreak in Europe

Outbreak of mpox in Europe

The 2022–2023 mpox outbreak in Europe was part of a global outbreak of mpox, a viral disease caused by the monkeypox virus. The outbreak was first identified in May 2022 and involved multiple countries across Europe.

Background

Mpox is a zoonotic disease caused by the monkeypox virus, which is a member of the Orthopoxvirus genus. The disease is characterized by symptoms similar to those of smallpox, though generally less severe. The virus is endemic to certain regions of Central Africa and West Africa.

Outbreak timeline

The outbreak in Europe began in May 2022, with initial cases reported in the United Kingdom. The virus quickly spread to other European countries, including Spain, Portugal, Germany, and France. By the end of 2022, cases had been reported in nearly every European country.

Initial cases

The first cases in Europe were identified in the United Kingdom, where health authorities reported several cases of mpox in individuals with no travel history to endemic regions. This suggested local transmission of the virus.

Spread across Europe

The virus spread rapidly across Europe, with significant clusters of cases reported in Spain and Portugal. The outbreak was characterized by human-to-human transmission, primarily through close contact.

Symptoms and transmission

Stages of monkeypox lesion development

The symptoms of mpox include fever, headache, muscle aches, and a characteristic rash that progresses through several stages, as shown in the image. The rash typically begins on the face and spreads to other parts of the body.

Transmission of the virus occurs through direct contact with the lesions, bodily fluids, or respiratory droplets of an infected person. The virus can also spread through contact with contaminated materials, such as bedding or clothing.

Public health response

European health authorities implemented various measures to control the outbreak, including contact tracing, isolation of infected individuals, and vaccination campaigns. The smallpox vaccine was used as a preventive measure due to its effectiveness against mpox.

Impact

The outbreak had significant public health implications, straining healthcare systems and prompting international collaboration to control the spread of the virus. The outbreak also raised awareness about the potential for zoonotic diseases to cause global health emergencies.

Conclusion

The 2022–2023 mpox outbreak in Europe highlighted the importance of surveillance and rapid response to emerging infectious diseases. It underscored the need for global cooperation in addressing public health threats.

Related pages

• Mpox
• Monkeypox virus
• Zoonotic disease
• Smallpox